Small-Cap Logistics Company Partners with Aphria to Deliver Medical Cannabis
Source: Streetwise Reports  (8/22/19)
The initiative, to start in Calgary, is expected to expand rapidly into other cities. More >

Life Sciences Firm's OxC-beta Approved for Livestock Feed in Mexico
Source: Streetwise Reports  (8/21/19)
The country represents a significant market for feed consumption. More >

'Data Readouts Approaching in Two Pivotal Trials' for Biopharma Targeting Unmet Needs
Source: Streetwise Reports  (8/20/19)
The next steps for each of the programs are outlined in a Dawson James Securities report. More >

Analyst Upgrade Ignites Duchenne's Muscular Dystrophy Research Firm's Shares
Source: Streetwise Reports  (8/16/19)
Solid Biosciences' shares are up by more than 40% today after Chardan Capital Markets upgraded the firm's shares from "neutral" to "buy" and raised its price target from $7.50 to $10.00/share. More >

Deciphera's Shares Open 115% Higher on Phase 3 Ripretinib Results
Source: Streetwise Reports  (8/13/19)
Deciphera Pharmaceuticals announced positive top-line results from the INVICTUS pivotal phase 3 clinical study of ripretinib in patients with advanced gastrointestinal stromal tumors. More >

Biotech's DMD Therapeutic 'Solidifies the Ground for Potential Pivotal Design'
Source: Streetwise Reports  (8/12/19)
The latest development concerning this clinical asset and other Q2/19 highlights are provided in an H.C. Wainwright & Co. report. More >

Amgen Shares React Favorably to Enbrel Patent Case Victory
Source: Streetwise Reports  (8/12/19)
Amgen shares are trading 5–6% higher today on news that the company has won its Enbrel (etanercept) patent court case. More >

Puma Biotech Shares Up More Than 20% on Q2 Earnings and Breast Cancer Drug Sales
Source: Streetwise Reports  (8/9/19)
Shares in Puma Biotechnology are trading 20% higher today after the company released Q2/19 earnings and reported positive NERLYNX revenue growth. More >

Avedro Shares Looking Up 35% with Glaukos Merger
Source: Streetwise Reports  (8/8/19)
Avedro Inc. and Glaukos Corp. announced that the firms' boards of directors have executed a definitive merger agreement. The all-stock deal is expected to close in Q4/19. More >

Guardant Health Reports Quarterly Revenue Up 178%
Source: Streetwise Reports  (8/7/19)
Guardant Health Inc. reported strong growth for Q2/19 versus the same period last year and raised its full-year 2019 revenue guidance to $180–190 million. More >

Allakos Shares Double on AK002 Phase 2 Results and Earnings
Source: Streetwise Reports  (8/5/19)
Allakos Inc. shares are soaring today as the company reported Q2/19 earnings and announced positive results from its phase 2 study for its AK002 inhibitor used in the treatment of eosinophil and mast cell related diseases. More >

Gaia Grow Corp. Plants 1,494 Acres of Hemp in Canada and Plans First Harvest in 2 Months
Source: Peter Epstein for Streetwise Reports  (8/1/19)
Gaia Grow Corp. CEO Frederick Pels speaks with Peter Epstein of Epstein Research on the day his company begins trading on the TSX Venture Exchange. More >

Led by Sales of HETLIOZ, Vanda Increases Quarterly Revenues by 25%
Source: Streetwise Reports  (8/1/19)
Shares of Vanda Pharmaceuticals traded nearly 30% higher after the company released Q2/19 earnings and positive sales trends for both HETLIOZ and Fanapt. More >

EMA Opinion Bodes Well for Biopharma's Drug Getting Orphan Status
Source: Streetwise Reports  (7/31/19)
The designation, opinion and asset are discussed in a ROTH Capital Partners report. More >

Mylan Gets a Shot in the Arm with Pfizer Merger Deal
Source: Streetwise Reports  (7/29/19)
EpiPen manufacturer Mylan N.V. announced that the company will merge with Pfizer Inc.'s Upjohn Division, which holds Pfizer's off-patent branded and generic drugs, forming a new company. More >

Anixa Licenses Another Potential Blockbuster
Source: Daniel Carlson for Streetwise Reports  (7/24/19)
Daniel Carlson of Tailwinds Research discusses a major collaboration with the Cleveland Clinic for his top pick stock of the year. More >

Edwards Lifesciences Gets a Charge on Positive Q2 Earnings Report
Source: Streetwise Reports  (7/24/19)
Edwards Lifesciences is trading higher after reporting higher than expected adjusted earnings for Q2/19. The company estimates that the FDA will approve its SAPIEN 3 valve and SAPIEN 3 Ultra system in Q3/19. More >

Biotech Firm ''Creating Innovative Solutions' for Female Health
Source: Streetwise Reports  (7/23/19)
The company's most advanced assets are discussed in a Dawson James Securities report. More >

Interim Data Indicate Multiantigen Cell Therapy in Solid Tumors 'Just Might Work'
Source: Streetwise Reports  (7/23/19)
The immuno-oncology company's findings are reviewed in a ROTH Capital Partners report. More >

Biopharma's New License Agreement with Gilead 'Brings Strong Validation and Economics'
Source: Streetwise Reports  (7/23/19)
The specifics and benefits of the deal are discussed in an H.C. Wainwright & Co. report. More >

Biopharma Presents Data on Its Therapeutic Candidates at Alzheimer's Conference
Source: Streetwise Reports  (7/22/19)
The company discussed both its Alzheimer's disease and ALS programs. More >

Biopharma Licenses Sustained Release Technology to Gilead for HIV Product
Source: Streetwise Reports  (7/22/19)
The two California-based companies will collaborate on specific related development activities. More >

Biopharma Receives PDUFA Goal Date for Nonopioid Pain Drug
Source: Streetwise Reports  (7/18/19)
The FDA deemed the firm's submission for analgesic approval complete. More >

Top Pick Status Given to Small-Cap with Pain Drug Candidate
Source: Streetwise Reports  (7/17/19)
The primary reason for the rating—upcoming trial results—is discussed in an Echelon Wealth Partners report. More >

Seattle Genetics Shares Head Higher After Positive Earnings and ADCETRIS Sales Expansion
Source: Streetwise Reports  (7/17/19)
Seattle Genetics announced a 28.3% increase in net sales for its second quarter 2019 powered by ADCETRIS sales along with a promising pipeline. More >